Pular para o conteúdo
· Skin boosters
SKU 11122

Aquashine HA

Em stock
Volume
1 x 2 mL
Laboratório
Caregen Co., Ltd.
Origem
Coreia do Sul
Indicação
Skin hydration, revitalization and age-related correction
Zonas de tratamento
O preço profissional e o histórico são exclusivos de contas verificadas
allpara fornece profissionais licenciados. Inicie sessão ou peça uma conta B2B para ver os preços em tempo real, os escalões por volume e o histórico de preços.
Etiquetas

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Principais vantagens de Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Informação essencial
Marca AQUASHINE
Fabricante Caregen Co., Ltd.
País de origem South Korea
Certificação CE marked (per MDD 93/42/EEC)
Composição Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
Volume / Tamanho 2 ml
Embalagem 1 x 2 mL
Tamanho da agulha 30G (0.30 x 13 mm)
Tipo de utilização For professional use - intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
Profundidade de injeção Middle and superficial dermis
Protocolo / Duração Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

Indicações e utilização profissional

Principais indicações

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

Utilização profissional

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

Zonas de tratamento

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

Perfil do paciente

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

Como funciona Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Porquê encomendar na Allpara

A Allpara oferece produtos AQUASHINE originais e verificados de fornecedores selecionados, com rastreabilidade total dos lotes e apoio especializado. Servimos clínicas e profissionais de estética com produtos com certificação CE, entrega rápida em toda a UE a partir do nosso armazém na UE e preços profissionais competitivos. A nossa prioridade é a segurança, a satisfação e os resultados dos seus pacientes, com apoio pós-venda dedicado para a sua tranquilidade.

Perguntas frequentes

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

Mais de Caregen

Ver laboratório

Alternativas para a clínica

Todos os produtos

Aquashine HA

Em stock
Marcação CE Marcação CE Aquashine HA
Preços exclusivos para contas verificadas
Inicie sessão ou peça uma conta B2B para ver o seu preço.
Pedir conta B2B

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Principais vantagens de Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Informação essencial
Marca AQUASHINE
Fabricante Caregen Co., Ltd.
País de origem South Korea
Certificação CE marked (per MDD 93/42/EEC)
Composição Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
Volume / Tamanho 2 ml
Embalagem 1 x 2 mL
Tamanho da agulha 30G (0.30 x 13 mm)
Tipo de utilização For professional use - intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
Profundidade de injeção Middle and superficial dermis
Protocolo / Duração Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

Indicações e utilização profissional

Principais indicações

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

Utilização profissional

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

Zonas de tratamento

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

Perfil do paciente

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

Como funciona Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Porquê encomendar na Allpara

A Allpara oferece produtos AQUASHINE originais e verificados, com rastreabilidade total dos lotes, stock com certificação CE, entrega rápida em toda a UE e apoio pós-venda especializado.

Perguntas frequentes

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

Mais de Caregen

Ver o laboratório →
* Produto de uso profissional. A embalagem pode variar consoante o lote ou o mercado. Consulte as instruções de utilização fornecidas para as indicações completas e as contraindicações.